Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Olsen

Showing results (861-870 of 1,016) with videos related to

Pageof 102
Sort By:
Infection Control and Hospital Epidemiology|June 29, 2023
Early coronavirus disease 2019 (COVID-19) pandemic effects on individual-level risk for healthcare-associated infections in hospitalized patientsTrevor S Farthing, Ashlan Jolley, Katelin B Nickel, et al.
Journal of the American Academy of Dermatology|May 23, 2001
A phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphomaM Duvic, E A Olsen, G A Omura, et al.
ACS Medicinal Chemistry Letters|October 11, 2011
Potential Agents for Treating Cystic Fibrosis: Cyclic Tetrapeptides that Restore Trafficking and Activity of ΔF508-CFTRDarren M Hutt, Christian A Olsen, Chris J Vickers, et al.
Practical Radiation Oncology|November 22, 2014
Contouring variations and the role of atlas in non-small cell lung cancer radiation therapy: Analysis of a multi-institutional preclinical trial planning studyYunfeng Cui, Wenzhou Chen, Feng-Ming Spring Kong, et al.
Child Development|July 20, 2010
Unpacking trauma exposure risk factors and differential pathways of influence: predicting postwar mental distress in Bosnian adolescentsChristopher M Layne, Joseph A Olsen, Aaron Baker, et al.
Journal of Prosthodontics : Official Journal of the American College of Prosthodontists|December 30, 2015
Clinical Practice Guidelines for Recall and Maintenance of Patients with Tooth-Borne and Implant-Borne Dental RestorationsAvinash S Bidra, Diane M Daubert, Lily T Garcia, et al.
International Journal of Radiation Oncology, Biology, Physics|April 8, 2015
Quantifying Unnecessary Normal Tissue Complication Risks due to Suboptimal Planning: A Secondary Study of RTOG 0126Kevin L Moore, Rachel Schmidt, Vitali Moiseenko, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 21, 2014
Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous T-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome)R Dummer, M Duvic, J Scarisbrick, et al.
Infection Control and Hospital Epidemiology|December 17, 2011
Use of Medicare diagnosis and procedure codes to improve detection of surgical site infections following hip arthroplasty, knee arthroplasty, and vascular surgeryMichael S Calderwood, Allen Ma, Yosef M Khan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphomaElise A Olsen, Youn H Kim, Timothy M Kuzel, et al.
Pageof 102

Showing results (861-870 of 1,016) with videos related to

Sort By:
Pageof 102
Infection Control and Hospital Epidemiology|June 29, 2023
Early coronavirus disease 2019 (COVID-19) pandemic effects on individual-level risk for healthcare-associated infections in hospitalized patientsTrevor S Farthing, Ashlan Jolley, Katelin B Nickel, et al.
Journal of the American Academy of Dermatology|May 23, 2001
A phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphomaM Duvic, E A Olsen, G A Omura, et al.
ACS Medicinal Chemistry Letters|October 11, 2011
Potential Agents for Treating Cystic Fibrosis: Cyclic Tetrapeptides that Restore Trafficking and Activity of ΔF508-CFTRDarren M Hutt, Christian A Olsen, Chris J Vickers, et al.
Practical Radiation Oncology|November 22, 2014
Contouring variations and the role of atlas in non-small cell lung cancer radiation therapy: Analysis of a multi-institutional preclinical trial planning studyYunfeng Cui, Wenzhou Chen, Feng-Ming Spring Kong, et al.
Child Development|July 20, 2010
Unpacking trauma exposure risk factors and differential pathways of influence: predicting postwar mental distress in Bosnian adolescentsChristopher M Layne, Joseph A Olsen, Aaron Baker, et al.
Journal of Prosthodontics : Official Journal of the American College of Prosthodontists|December 30, 2015
Clinical Practice Guidelines for Recall and Maintenance of Patients with Tooth-Borne and Implant-Borne Dental RestorationsAvinash S Bidra, Diane M Daubert, Lily T Garcia, et al.
International Journal of Radiation Oncology, Biology, Physics|April 8, 2015
Quantifying Unnecessary Normal Tissue Complication Risks due to Suboptimal Planning: A Secondary Study of RTOG 0126Kevin L Moore, Rachel Schmidt, Vitali Moiseenko, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 21, 2014
Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous T-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome)R Dummer, M Duvic, J Scarisbrick, et al.
Infection Control and Hospital Epidemiology|December 17, 2011
Use of Medicare diagnosis and procedure codes to improve detection of surgical site infections following hip arthroplasty, knee arthroplasty, and vascular surgeryMichael S Calderwood, Allen Ma, Yosef M Khan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphomaElise A Olsen, Youn H Kim, Timothy M Kuzel, et al.
Pageof 102